Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs targeting oncological and inflammatory diseases, today ...
The glioblastoma clinical trial analysis report delivers important insights into ongoing research of 220+ pipeline glioblastoma drugs, clinical strategies, upcoming therapeutics, and commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results